BOSTON SCIENTIFIC CORP

Surgical & Medical Instruments & Apparatus·MARLBOROUGH, MA·FY end 12/31·CIK 885725

CEO Pay Ratio

348:1

Michael F. Mahoney

CEO Total Comp

$23.5M

Michael F. Mahoney

Median Employee

—

Revenue

$20.1B

FY 2025

Net Income

—

FY 2025

Free Cash Flow

$3.7B

FY 2025

Net Margin

—

Insider Net (180d)

-$15.0M

0 buys / 2 sales

CEO Pay Accountability

CEO comp as % of net income

—

Not enough data to compute.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$20.1B	$16.7B	$14.2B	$12.7B	$11.9B
Gross Profit	$13.9B	$11.5B	$9.9B	$8.7B	$8.2B
Operating Income	$3.6B	$2.6B	$2.3B	$1.6B	$1.2B
Net Income	—	—	—	—	—	—
Operating CF	$4.5B	$3.4B	$2.5B	$1.5B	$1.9B
Capex	$876.0M	$790.0M	$711.0M	$588.0M	$554.0M
Free Cash Flow	$3.7B	$2.6B	$1.8B	$938.0M	$1.3B
Buybacks	—	—	—	$0	$0
Dividends	—	—	—	—	—	—

Gross Margin	69.0%	68.6%	69.5%	68.8%	68.8%
Operating Margin	18.0%	15.5%	16.5%	13.0%	10.1%
Net Margin	—	—	—	—	—	—
FCF Margin	18.2%	15.8%	12.6%	7.4%	11.1%
R&D / Revenue	—	—	—	—	—	—
Effective Tax	14.6%	19.1%	19.8%	38.8%	3.3%
Debt / Equity	—	—	—	—	—	—
Buybacks / FCF	—	—	—	0.0%	0.0%

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Michael F. MahoneyChairman of the Board, President and Chief Executive Officer	$1.4M	$13.6M	$3.7M	$4.0M	$729.4K	$23.5M
Joseph M. FitzgeraldExecutive Vice President and Group President, Cardiovascular	$892.6K	$4.3M	$1.2M	$1.5M	$195.6K	$8.0M
Arthur C. ButcherExecutive Vice President and Group President, MedSurg and Asia Pacific	$744.8K	$3.4M	$950.0K	$1.0M	$380.2K	$6.5M
Daniel J. BrennanFormer Executive Vice President and Chief Financial Officer	$661.0K	$3.4M	$950.0K	$1.1M	$126.7K	$6.3M
Jonathan R. Monson	$591.8K	$1.6M	$1.2M	$840.0K	$1.9M	$6.1M
Jeffrey B. MirvissExecutive Vice President and President, Peripheral Interventions	$702.0K	$2.0M	$550.0K	$793.1K	$119.2K	$4.2M
Vance R. Brown	$659.1K	$1.7M	$475.0K	$897.8K	$165.2K	$3.9M
David A. Pierce	—	—	—	—	—	—